4//SEC Filing
HAUMANN BRETT K 4
Accession 0001179110-20-006524
CIK 0001583107other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:06 PM ET
Size
4.4 KB
Accession
0001179110-20-006524
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2020-05-20$26.67/sh−4,212$112,334→ 312,456 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607733
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 6:06 PM ET
- Size
- 4.4 KB